263 related articles for article (PubMed ID: 12715330)
1. Are epidermal growth factor and transforming growth factor responsible for pseudoepitheliomatous hyperplasia associated with granular cell tumors?
Barkan GA; Paulino AF
Ann Diagn Pathol; 2003 Apr; 7(2):73-7. PubMed ID: 12715330
[TBL] [Abstract][Full Text] [Related]
2. Quantitative immunohistochemical analysis of transforming growth factor-alpha and epidermal growth factor receptor in patients with squamous cell carcinoma of the head and neck.
Rubin Grandis J; Melhem MF; Barnes EL; Tweardy DJ
Cancer; 1996 Sep; 78(6):1284-92. PubMed ID: 8826952
[TBL] [Abstract][Full Text] [Related]
3. Expression of TGFalpha autocrine activity in human colon carcinoma CBS cells is autoregulated and independent of exogenous epidermal growth factor.
Jiang D; Liang J; Humphrey LE; Yang H; Brattain MG
J Cell Physiol; 1998 May; 175(2):174-83. PubMed ID: 9525476
[TBL] [Abstract][Full Text] [Related]
4. The EGF receptor system in head and neck carcinomas and normal tissues. Immunohistochemical and quantitative studies.
Christensen ME
Dan Med Bull; 1998 Apr; 45(2):121-34. PubMed ID: 9587699
[TBL] [Abstract][Full Text] [Related]
5. Morphometrical differences between pseudo-epitheliomatous hyperplasia in granular cell tumours and squamous cell carcinomas.
Abu-Eid R; Landini G
Histopathology; 2006 Mar; 48(4):407-16. PubMed ID: 16487362
[TBL] [Abstract][Full Text] [Related]
6. Elevated levels of transforming growth factor alpha and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer.
Grandis JR; Tweardy DJ
Cancer Res; 1993 Aug; 53(15):3579-84. PubMed ID: 8339264
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical expression of transforming growth factor alpha and epidermal growth factor receptor in pancreatic endocrine tumors.
Srivastava A; Alexander J; Lomakin I; Dayal Y
Hum Pathol; 2001 Nov; 32(11):1184-9. PubMed ID: 11727256
[TBL] [Abstract][Full Text] [Related]
8. Dysregulation of epidermal growth factor receptor expression in premalignant lesions during head and neck tumorigenesis.
Shin DM; Ro JY; Hong WK; Hittelman WN
Cancer Res; 1994 Jun; 54(12):3153-9. PubMed ID: 8205534
[TBL] [Abstract][Full Text] [Related]
9. Asynchronous modulation of transforming growth factor alpha and epidermal growth factor receptor protein expression in progression of premalignant lesions to head and neck squamous cell carcinoma.
Rubin Grandis J; Tweardy DJ; Melhem MF
Clin Cancer Res; 1998 Jan; 4(1):13-20. PubMed ID: 9516947
[TBL] [Abstract][Full Text] [Related]
10. Induction of heparin-binding EGF-like growth factor and activation of EGF receptor in imatinib mesylate-treated squamous carcinoma cells.
Johnson FM; Saigal B; Donato NJ
J Cell Physiol; 2005 Nov; 205(2):218-27. PubMed ID: 15887238
[TBL] [Abstract][Full Text] [Related]
11. Pseudocarcinomatous change in lymphomatoid papulosis and primary cutaneous CD30+ lymphoma: a clinicopathologic and immunohistochemical study of 6 patients.
Scarisbrick JJ; Calonje E; Orchard G; Child FJ; Russell-Jones R
J Am Acad Dermatol; 2001 Feb; 44(2):239-47. PubMed ID: 11174381
[TBL] [Abstract][Full Text] [Related]
12. Heparin-binding epidermal growth factor-like growth factor isoforms and epidermal growth factor receptor/ErbB1 expression in bladder cancer and their relation to clinical outcome.
Kramer C; Klasmeyer K; Bojar H; Schulz WA; Ackermann R; Grimm MO
Cancer; 2007 May; 109(10):2016-24. PubMed ID: 17394193
[TBL] [Abstract][Full Text] [Related]
13. Differentiation or immune destruction: two pathways for therapy of squamous cell carcinomas with antibodies to the epidermal growth factor receptor.
Modjtahedi H; Eccles S; Sandle J; Box G; Titley J; Dean C
Cancer Res; 1994 Apr; 54(7):1695-701. PubMed ID: 8137284
[TBL] [Abstract][Full Text] [Related]
14. Epidermal growth factor receptor: a novel biomarker for aggressive head and neck cutaneous squamous cell carcinoma.
Ch'ng S; Low I; Ng D; Brasch H; Sullivan M; Davis P; Tan ST
Hum Pathol; 2008 Mar; 39(3):344-9. PubMed ID: 18045646
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical evidence of autocrine growth factors in adenocarcinoma of the human lung.
Tateishi M; Ishida T; Mitsudomi T; Kaneko S; Sugimachi K
Cancer Res; 1990 Nov; 50(21):7077-80. PubMed ID: 2208175
[TBL] [Abstract][Full Text] [Related]
16. Immunoreactive transforming growth factor alpha and epidermal growth factor in oral squamous cell carcinomas.
Christensen ME; Therkildsen MH; Poulsen SS; Bretlau P
J Pathol; 1993 Mar; 169(3):323-8. PubMed ID: 8492225
[TBL] [Abstract][Full Text] [Related]
17. Expression of epithelial growth factor receptor and its two ligands, transforming growth factor-alpha and epithelial growth factor, in normal and neoplastic squamous cells in the vulva: an immunohistochemical study.
Wu X; Xin Y; Yao J; Hasui K; Tsuyama S; Yonezawa S; Murata F
Med Electron Microsc; 2001 Sep; 34(3):179-84. PubMed ID: 11793194
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of growth factors in squamous cell carcinoma and precancerous lesions of the lung.
Piyathilake CJ; Frost AR; Manne U; Weiss H; Bell WC; Heimburger DC; Grizzle WE
Clin Cancer Res; 2002 Mar; 8(3):734-44. PubMed ID: 11895903
[TBL] [Abstract][Full Text] [Related]
19. Protein kinase C zeta mediates epidermal growth factor-induced growth of head and neck tumor cells by regulating mitogen-activated protein kinase.
Cohen EE; Lingen MW; Zhu B; Zhu H; Straza MW; Pierce C; Martin LE; Rosner MR
Cancer Res; 2006 Jun; 66(12):6296-303. PubMed ID: 16778206
[TBL] [Abstract][Full Text] [Related]
20. Is immunohistochemical epidermal growth factor receptor expression overestimated as a prognostic factor in head-neck squamous cell carcinoma? A retrospective analysis based on a tissue microarray of 365 carcinomas.
Fischer C; Zlobec I; Stöckli E; Probst S; Storck C; Tornillo L; Lugli A; Wolfensberger M; Terracciano L
Hum Pathol; 2008 Oct; 39(10):1527-34. PubMed ID: 18620726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]